56
Views
4
CrossRef citations to date
0
Altmetric
Articles

Photocatalytic treatment of colored wastewater from medical laboratories: photodegradation of Nuclear Fast Red

, , , , , & show all
Pages 18897-18905 | Received 05 Mar 2015, Accepted 05 Sep 2015, Published online: 30 Sep 2015
 

Abstract

The degradation and organic content reduction of Nuclear Fast Red (NFR, a counterstain reagent widely used in biochemical and biomedical laboratories) in aqueous solutions has been studied by heterogeneous photocatalytic oxidation under artificial irradiation. For the heterogeneous processes, the performance of different commercial titanium oxides on the degradation and the organic content reduction (DOC) of the wastewater was examined. The decomposition of the NFR follows quite well a pseudo-first kinetic order in the whole pH range, in line with the Langmuir–Hinshelwood model. The effects of catalyst concentration, of the initial solution pH and of H2O2 concentration upon the reaction rate, were also investigated. NFR degradation was accompanied by the formation of ammonium, nitrate, and sulfate ions, as they have been detected as mineralization products in the liquid phase.

Acknowledgements

This study is implemented within the framework of the Action Joint Research and Technology Programmes Greece–Romania 2011–2012 and is co-financed by the European Social Fund (ESF) and the Greek State.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.